These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9761246)
1. Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Gelmini S; Caldini A; Becherini L; Capaccioli S; Pazzagli M; Orlando C Clin Chem; 1998 Oct; 44(10):2133-8. PubMed ID: 9761246 [TBL] [Abstract][Full Text] [Related]
2. A quantitative method to measure telomerase activity by bioluminescence connected with telomeric repeat amplification protocol. Xu S; He M; Yu H; Cai X; Tan X; Lu B; Shu B Anal Biochem; 2001 Dec; 299(2):188-93. PubMed ID: 11730342 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease. Xinarianos G; Scott FM; Liloglou T; Prime W; Turnbull L; Walshaw M; Field JK Lung Cancer; 2000 Apr; 28(1):37-42. PubMed ID: 10704707 [TBL] [Abstract][Full Text] [Related]
4. A fluorescent method for detection of telomerase activity. Aldous WK; Grabill NR Diagn Mol Pathol; 1997 Apr; 6(2):102-10. PubMed ID: 9098649 [TBL] [Abstract][Full Text] [Related]
5. Detection of telomerase activity in breast masses by fine-needle aspiration. Pearson AS; Gollahon LS; O'Neal NC; Saboorian H; Shay JW; Fahey TJ Ann Surg Oncol; 1998 Mar; 5(2):186-93. PubMed ID: 9527273 [TBL] [Abstract][Full Text] [Related]
6. SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Wege H; Chui MS; Le HT; Tran JM; Zern MA Nucleic Acids Res; 2003 Jan; 31(2):E3-3. PubMed ID: 12527792 [TBL] [Abstract][Full Text] [Related]
7. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Hou M; Xu D; Björkholm M; Gruber A Clin Chem; 2001 Mar; 47(3):519-24. PubMed ID: 11238306 [TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; Nargund V; Fellows G; Goodison S; Tahara E; Tarin D Cancer; 1997 Jan; 79(2):362-9. PubMed ID: 9010110 [TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in periampullary tumors correlates with aggressive malignancy. Balcom JH; Keck T; Warshaw AL; Antoniu B; Graeme-Cook F; Fernández-del Castillo C Ann Surg; 2001 Sep; 234(3):344-50; discussion 350-1. PubMed ID: 11524587 [TBL] [Abstract][Full Text] [Related]
10. A quantitative assay of telomerase activity. Gan Y; Lu J; Johnson A; Wientjes MG; Schuller DE; Au JL Pharm Res; 2001 Apr; 18(4):488-93. PubMed ID: 11451036 [TBL] [Abstract][Full Text] [Related]
11. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Ohyashiki K; Ohyashiki JH; Nishimaki J; Toyama K; Ebihara Y; Kato H; Wright WE; Shay JW Cancer Res; 1997 Jun; 57(11):2100-3. PubMed ID: 9187102 [TBL] [Abstract][Full Text] [Related]
12. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463 [TBL] [Abstract][Full Text] [Related]
13. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. Hirose M; Abe-Hashimoto J; Ogura K; Tahara H; Ide T; Yoshimura T J Cancer Res Clin Oncol; 1997; 123(6):337-44. PubMed ID: 9222300 [TBL] [Abstract][Full Text] [Related]
14. [Techniques for detection of telomerase activity in tissue samples. Diagnostic and prognosis importance]. Brousset P; al Saati T; Chaouche N; Zenou RC; Mazerolles C; Delsol G Ann Pathol; 1997 Oct; 17(5):364-8. PubMed ID: 9471158 [TBL] [Abstract][Full Text] [Related]
15. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas. Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691 [TBL] [Abstract][Full Text] [Related]
16. Telomerase detection in body fluids. Hess JL; Highsmith WE Clin Chem; 2002 Jan; 48(1):18-24. PubMed ID: 11751534 [TBL] [Abstract][Full Text] [Related]
17. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. Kinoshita H; Ogawa O; Mitsumori K; Kakehi Y; Terachi T; Yoshida O J Urol; 1998 Jan; 159(1):245-51. PubMed ID: 9400489 [TBL] [Abstract][Full Text] [Related]
18. Measurement of telomerase activity in dog tumors. Yazawa M; Okuda M; Setoguchi A; Nishimura R; Sasaki N; Hasegawa A; Watari T; Tsujimoto H J Vet Med Sci; 1999 Oct; 61(10):1125-9. PubMed ID: 10563290 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in human urothelial tumors. Kyo S; Kunimi K; Uchibayashi T; Namiki M; Inoue M Am J Clin Pathol; 1997 May; 107(5):555-60. PubMed ID: 9128268 [TBL] [Abstract][Full Text] [Related]
20. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays. Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]